Kura Oncology (KURA) News Today $5.64 -0.60 (-9.62%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$5.70 +0.06 (+1.06%) As of 05/23/2025 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KURA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Kura Oncology to present trial results for AML treatmentMay 24 at 11:33 PM | investing.comRafferty Asset Management LLC Grows Stock Holdings in Kura Oncology, Inc. (NASDAQ:KURA)Rafferty Asset Management LLC raised its holdings in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 58.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 145,614 shares of the company's stock after acquirMay 24 at 4:24 AM | marketbeat.comKura Oncology, Inc. (KURA) and Kyowa Kirin to Present Promising Ziftomenib Data at ASCO 2025May 23 at 11:45 AM | insidermonkey.comMillennium Management LLC Buys 1,521,954 Shares of Kura Oncology, Inc. (NASDAQ:KURA)Millennium Management LLC lifted its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 180.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,367,148 shares of the company's stock after purchasing an aMay 23 at 4:09 AM | marketbeat.comKura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual MeetingMay 22 at 5:30 PM | globenewswire.comVelan Capital Investment Management LP Buys Shares of 150,000 Kura Oncology, Inc. (NASDAQ:KURA)Velan Capital Investment Management LP acquired a new position in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 150,000 shares of the company'sMay 21, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Stock Position Raised by BNP Paribas Financial MarketsBNP Paribas Financial Markets lifted its position in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 969.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 163,559 shares of the company's stock after acquiring an additional 1May 21, 2025 | marketbeat.comKura Oncology to Participate in Three Upcoming Investor ConferencesMay 20, 2025 | globenewswire.comKura Oncology Q3 EPS Estimate Lowered by Leerink PartnrsMay 20, 2025 | americanbankingnews.comLeerink Partnrs Lowers Earnings Estimates for Kura OncologyKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities research analysts at Leerink Partnrs decreased their Q3 2025 earnings per share estimates for Kura Oncology in a note issued to investors on Wednesday, May 14th. Leerink Partnrs analyst J. Chang now expects that the company will post earnMay 20, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Price Target Cut to $30.00 by Analysts at MizuhoMay 20, 2025 | americanbankingnews.comSuvretta Capital Management LLC Lowers Holdings in Kura Oncology, Inc. (NASDAQ:KURA)Suvretta Capital Management LLC decreased its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 33.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,076,448 shares of the company's stock after selMay 19, 2025 | marketbeat.comGraham Capital Management L.P. Takes $444,000 Position in Kura Oncology, Inc. (NASDAQ:KURA)Graham Capital Management L.P. purchased a new stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 50,949 shares of the company's stock, valued atMay 19, 2025 | marketbeat.comProsight Management LP Purchases 619,891 Shares of Kura Oncology, Inc. (NASDAQ:KURA)Prosight Management LP raised its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 87.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,325,000 shares of the company's stock after puMay 17, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Has $10.03 Million Stock Holdings in Kura Oncology, Inc. (NASDAQ:KURA)D. E. Shaw & Co. Inc. raised its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 172.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,151,195 shares of the company's stock aftMay 17, 2025 | marketbeat.com977,920 Shares in Kura Oncology, Inc. (NASDAQ:KURA) Bought by Jacobs Levy Equity Management Inc.Jacobs Levy Equity Management Inc. purchased a new position in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 977,920 shares of the company's stoMay 16, 2025 | marketbeat.comVoya Investment Management LLC Decreases Stock Holdings in Kura Oncology, Inc. (NASDAQ:KURA)Voya Investment Management LLC cut its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 71.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 22,016 shares of the company's stock after sellingMay 16, 2025 | marketbeat.comKura Oncology and Kyowa Kirin Announce Combination Data for Ziftomenib in Oral Presentation at the 2025 European Hematology Association (EHA) CongressMay 14, 2025 | globenewswire.comKura Oncology, Inc. (NASDAQ:KURA) Holdings Reduced by Foresite Capital Management IV LLCForesite Capital Management IV LLC lowered its holdings in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 6.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,726,882 shares of the company's stock after sellingMay 12, 2025 | marketbeat.comDimensional Fund Advisors LP Buys 372,196 Shares of Kura Oncology, Inc. (NASDAQ:KURA)Dimensional Fund Advisors LP boosted its position in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 35.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,425,960 shares of thMay 12, 2025 | marketbeat.comKura Oncology’s SWOT analysis: ziftomenib’s potential drives stock outlookMay 7, 2025 | investing.comKura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by Algert Global LLCAlgert Global LLC boosted its stake in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 224.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 883,703 shares of the company's stock after buying an additional 61May 7, 2025 | marketbeat.comBVF Inc. IL Sells 804,292 Shares of Kura Oncology, Inc. (NASDAQ:KURA)BVF Inc. IL reduced its position in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 23.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,567,469 shares of the company's stock after selling 804,292 shaMay 6, 2025 | marketbeat.comKura Oncology to Participate in Bank of America Securities Healthcare ConferenceMay 6, 2025 | globenewswire.comFY2026 EPS Estimates for Kura Oncology Increased by AnalystKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Stock analysts at Brookline Capital Management boosted their FY2026 earnings per share estimates for Kura Oncology in a research report issued to clients and investors on Thursday, May 1st. Brookline Capital Management analyst L. Cann now anticipaMay 6, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Given Average Rating of "Moderate Buy" by AnalystsShares of Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the thirteen brokerages that are currently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating, eight have gMay 6, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Shares Gap Down on Disappointing EarningsKura Oncology (NASDAQ:KURA) Shares Gap Down on Disappointing EarningsMay 4, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Price Target Lowered to $11.00 at BarclaysBarclays lowered their price objective on Kura Oncology from $32.00 to $11.00 and set an "overweight" rating for the company in a research report on Friday.May 4, 2025 | marketbeat.comScotiabank Keeps Their Hold Rating on Kura Oncology (KURA)May 4, 2025 | theglobeandmail.comBTIG Keeps Their Hold Rating on Kura Oncology (KURA)May 4, 2025 | theglobeandmail.comKura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by Aquatic Capital Management LLCAquatic Capital Management LLC increased its stake in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 327.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 79,917 shares of the company's stockMay 4, 2025 | marketbeat.comEarnings call transcript: Kura Oncology Q1 2025 reveals revenue boostMay 3, 2025 | investing.com4,451,041 Shares in Kura Oncology, Inc. (NASDAQ:KURA) Acquired by RA Capital Management L.P.RA Capital Management L.P. acquired a new position in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,451,041 shares of the companyMay 3, 2025 | marketbeat.comQ1 2025 Kura Oncology Inc Earnings CallMay 2, 2025 | finance.yahoo.comKura Oncology, Inc. (NASDAQ:KURA) Q1 2025 Earnings Call TranscriptMay 2, 2025 | msn.comKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 2, 2025 | globenewswire.comNebula Research & Development LLC Purchases Shares of 63,866 Kura Oncology, Inc. (NASDAQ:KURA)Nebula Research & Development LLC purchased a new stake in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 63,866 shares of the company's stock, vMay 2, 2025 | marketbeat.comTower Research Capital LLC TRC Acquires 46,613 Shares of Kura Oncology, Inc. (NASDAQ:KURA)Tower Research Capital LLC TRC lifted its position in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 889.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 51,852 shares of the company's stockMay 2, 2025 | marketbeat.comKura Oncology, Inc. (KURA) Q1 2025 Earnings Call TranscriptMay 1, 2025 | seekingalpha.comKura Oncology Reports First Quarter 2025 Financial ResultsMay 1, 2025 | globenewswire.comKura Oncology's (KURA) Market Outperform Rating Reiterated at JMP SecuritiesJMP Securities reissued a "market outperform" rating and issued a $28.00 price objective on shares of Kura Oncology in a research note on Tuesday.May 1, 2025 | marketbeat.comUncovering Potential: Kura Oncology's Earnings PreviewApril 30, 2025 | benzinga.comKura Oncology Q1 2025 Earnings PreviewApril 30, 2025 | msn.comKura Oncology (NASDAQ:KURA) Earns Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and set a $40.00 price objective on shares of Kura Oncology in a research note on Monday.April 30, 2025 | marketbeat.comKura doses first subjects in trial of ziftomenib for advanced GISTApril 29, 2025 | finance.yahoo.comKura Oncology Announces First Patients Dosed in Phase 1 Combination Trial of Ziftomenib for the Treatment of Advanced GISTApril 28, 2025 | globenewswire.comKura Oncology (KURA) Expected to Announce Quarterly Earnings on ThursdayKura Oncology (NASDAQ:KURA) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-kura-oncology-inc-stock/)April 26, 2025 | marketbeat.com948,905 Shares in Kura Oncology, Inc. (NASDAQ:KURA) Purchased by Marshall Wace LLPMarshall Wace LLP acquired a new stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 948,905 shares of the company's stock, valued at approximately $8,265,000. MarsApril 25, 2025 | marketbeat.comKura Oncology to Report First Quarter 2025 Financial ResultsApril 24, 2025 | globenewswire.comKura Oncology (NASDAQ:KURA) Shares Up 5.5% - What's Next?Kura Oncology (NASDAQ:KURA) Stock Price Up 5.5% - Time to Buy?April 23, 2025 | marketbeat.com Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address KURA Media Mentions By Week KURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KURA News Sentiment▼0.470.75▲Average Medical News Sentiment KURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KURA Articles This Week▼196▲KURA Articles Average Week Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VCEL News NAMS News AAPG News BLTE News HRMY News DNLI News KYMR News KNSA News CGON News TARS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KURA) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kura Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kura Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KURA Stock Free KURA Stock Alerts